Is direct acting antiviral therapy for hepatitis c viral infection associated with increased risk of hepatocellular carcinoma before or after liver transplantation?

被引：0
作者：
Jain, Ashokkumar [1 ]
Miller, Danielle [1 ]
Kadry, Zakiyah [1 ]
机构：
[1] Penn State Univ, Coll Med, Dept Surg, Div Transplant, Hershey, PA 17033 USA
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2019年 / 8卷 / 05期
关键词：
RECURRENCE;
D O I：
10.21037/hbsn.2019.05.10
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：563 / 565
页数：3
相关论文
共 10 条
[1]   Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts [J].
不详 .
JOURNAL OF HEPATOLOGY, 2016, 65 (04) :734-740
[2]   Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis [J].
Cheung, Michelle C. M. ;
Walker, Alex J. ;
Hudson, Benjamin E. ;
Verma, Suman ;
McLauchlan, John ;
Mutimer, David J. ;
Brown, Ashley ;
Gelson, William T. H. ;
MacDonald, Douglas C. ;
Agarwal, Kosh ;
Foster, Graham R. ;
Irving, William L. .
JOURNAL OF HEPATOLOGY, 2016, 65 (04) :741-747
[3]   Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals [J].
Conti, Fabio ;
Buonfiglioli, Federica ;
Scuteri, Alessandra ;
Crespi, Cristina ;
Bolondi, Luigi ;
Caraceni, Paolo ;
Foschi, Francesco Giuseppe ;
Lenzi, Marco ;
Mazzella, Giuseppe ;
Verucchi, Gabriella ;
Andreone, Pietro ;
Brillanti, Stefano .
JOURNAL OF HEPATOLOGY, 2016, 65 (04) :727-733
[4]   Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C [J].
Ioannou, George N. ;
Green, Pamela K. ;
Beste, Lauren A. ;
Mun, Elijah J. ;
Kerr, Kathleen F. ;
Berry, Kristin .
JOURNAL OF HEPATOLOGY, 2018, 69 (05) :1088-1098
[5]   Is there increased risk of hepatocellular carcinoma recurrence in liver transplant patients with direct-acting antiviral therapy? [J].
Jain, Ashokkumar ;
Miller, Danielle ;
Schreibman, Ian ;
Riley, Thomas R., III ;
Krok, Karen L. ;
Dohi, Takehiko ;
Sharma, Rajeev ;
Kadry, Zakiyah .
HEPATOLOGY INTERNATIONAL, 2019, 13 (02) :190-198
[6]   Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment [J].
Kozbial, Karin ;
Moser, Stephan ;
Schwarzer, Remy ;
Laferl, Hermann ;
Al-Zoairy, Ramona ;
Stauber, Rudolf ;
Staettermayer, Albert F. ;
Beinhardt, Sandra ;
Graziadei, Ivo ;
Freissmuth, Clarissa ;
Maieron, Andreas ;
Gschwantler, Michael ;
Strasser, Michael ;
Peck-Radosalvjevic, Markus ;
Trauner, Michael ;
Hofer, Harald ;
Ferenci, Peter .
JOURNAL OF HEPATOLOGY, 2016, 65 (04) :856-858
[7]   Sorafenib in advanced hepatocellular carcinoma [J].
Llovet, Josep M. ;
Ricci, Sergio ;
Mazzaferro, Vincenzo ;
Hilgard, Philip ;
Gane, Edward ;
Blanc, Jean-Frederic ;
Cosme de Oliveira, Andre ;
Santoro, Armando ;
Raoul, Jean-Luc ;
Forner, Alejandro ;
Schwartz, Myron ;
Porta, Camillo ;
Zeuzem, Stefan ;
Bolondi, Luigi ;
Greten, Tim F. ;
Galle, Peter R. ;
Seitz, Jean-Francois ;
Borbath, Ivan ;
Haussinger, Dieter ;
Giannaris, Tom ;
Shan, Minghua ;
Moscovici, Marius ;
Voliotis, Dimitris ;
Bruix, Jordi .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04) :378-390
[8]   Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy [J].
Reig, Maria ;
Marino, Zoe ;
Perello, Christie ;
Inarrairaegui, Mercedes ;
Ribeiro, Andrea ;
Lens, Sabela ;
Diaz, Alba ;
Vilana, Ramon ;
Darnell, Anna ;
Varela, Maria ;
Sangro, Bruno ;
Luis Calleja, Jose ;
Forns, Xavier ;
Bruix, Jordi .
JOURNAL OF HEPATOLOGY, 2016, 65 (04) :719-726
[9]  
Singal AG, 2019, GASTROENTEROLOGY, V156, P1215, DOI [10.1053/j.gastro.2018.08.066, 10.1053/j.gastro.2019.01.027]
[10]   Changes in Patient Backgrounds May Increase the Incidence of HCC After SVR in the Era of IFN-Free Therapy for HCV [J].
Toyoda, Hidenori ;
Kumada, Takashi ;
Tada, Toshifumi .
HEPATOLOGY, 2016, 64 (05) :1818-1819
1